Zachariah  Jonasson net worth and biography

Zachariah Jonasson Biography and Net Worth

Chief Financial Officer & Chief Business Officer of Absci

Zach Jonasson, PhD is the CFO and CBO of Absci. Prior to these roles, Dr. Jonasson served as an independent member of Absci's board of directors and as chairman of the board from April 2016 to October 2020.

Previously, Dr. Jonasson was a co-founder and Managing General Partner of two venture capital firms, Phoenix Venture Partners LLC (PVP) and Convergent Ventures, where he led both firm's venture capital investment strategies in the biotechnology sector. In those roles, he led investments in companies such as Absci, Valence Therapeutics (acquired by Recursion Pharmaceuticals), Sentinel Monitoring Systems (acquired by SUEZ), Totient (acquired by Absci), and ProFluent Bio, and he established fund investment partnerships with multinational corporations such as Pfizer, Corning, and L'Oreal. Earlier in his career, Dr. Jonasson was a General Partner at Seaflower Ventures, where he led multiple investments in companies including Serenex (acquired by Pfizer) and Metaworks (acquired by United Biosource Corporation) and was a co-founder of several companies, including Risk Capital Management and Corp Enhancement.

Dr Jonasson earned his PhD in Behavioral Neuroscience from Harvard University, where he was a Sackler Scholar, an AM in Statistics from Harvard University, and a BS in Economics from the Honors Program at Georgetown University.

What is Zachariah Jonasson's net worth?

The estimated net worth of Zachariah Jonasson is at least $1.44 million as of June 13th, 2024. Dr. Jonasson owns 384,751 shares of Absci stock worth more than $1,435,121 as of December 4th. This net worth evaluation does not reflect any other assets that Dr. Jonasson may own. Additionally, Dr. Jonasson receives a salary of $98,300.00 as Chief Financial Officer & Chief Business Officer at Absci. Learn More about Zachariah Jonasson's net worth.

How old is Zachariah Jonasson?

Dr. Jonasson is currently 50 years old. There are 2 older executives and no younger executives at Absci. The oldest executive at Absci is Dr. Andreas Busch Ph.D., Chief Innovation Officer & Member of Scientific Advisory Board, who is 61 years old. Learn More on Zachariah Jonasson's age.

What is Zachariah Jonasson's salary?

As the Chief Financial Officer & Chief Business Officer of Absci Corporation, Dr. Jonasson earns $98,300.00 per year. There are 2 executives that earn more than Dr. Jonasson. The highest earning executive at Absci is Dr. Andreas Busch Ph.D., Chief Innovation Officer & Member of Scientific Advisory Board, who commands a salary of $1,560,000.00 per year. Learn More on Zachariah Jonasson's salary.

How do I contact Zachariah Jonasson?

The corporate mailing address for Dr. Jonasson and other Absci executives is , , . Absci can also be reached via phone at 360-949-1041 and via email at [email protected]. Learn More on Zachariah Jonasson's contact information.

Has Zachariah Jonasson been buying or selling shares of Absci?

Zachariah Jonasson has not been actively trading shares of Absci over the course of the past ninety days. Most recently, Zachariah Jonasson sold 19,859 shares of the business's stock in a transaction on Thursday, June 13th. The shares were sold at an average price of $4.98, for a transaction totalling $98,897.82. Following the completion of the sale, the chief financial officer now directly owns 384,751 shares of the company's stock, valued at $1,916,059.98. Learn More on Zachariah Jonasson's trading history.

Who are Absci's active insiders?

Absci's insider roster includes Todd Bedrick (VP), Zachariah Jonasson (Chief Financial Officer & Chief Business Officer), Sarah Korman (General Counsel), Sean Mcclain (Insider), and Karen Mcginnis (Director). Learn More on Absci's active insiders.

Are insiders buying or selling shares of Absci?

In the last year, Absci insiders bought shares 3 times. They purchased a total of 155,785 shares worth more than $433,788.10. The most recent insider tranaction occured on September, 22nd when Director Menelas N Pangalos bought 95,785 shares worth more than $254,788.10. Insiders at Absci own 10.5% of the company. Learn More about insider trades at Absci.

Information on this page was last updated on 9/22/2025.

Zachariah Jonasson Insider Trading History at Absci

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/13/2024Sell19,859$4.98$98,897.82384,751View SEC Filing Icon  
See Full Table

Zachariah Jonasson Buying and Selling Activity at Absci

This chart shows Zachariah Jonasson's buying and selling at Absci by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Absci Company Overview

Absci logo
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Read More

Today's Range

Now: $3.73
Low: $3.29
High: $3.96

50 Day Range

MA: $3.62
Low: $2.64
High: $5.00

2 Week Range

Now: $3.73
Low: $2.01
High: $6.33

Volume

10,723,719 shs

Average Volume

4,379,107 shs

Market Capitalization

$560.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.13